期刊文献+

解读欧洲Graves眼病专家组管理共识 被引量:4

Explication of consensus statement of the European group on Graves' orbitopathy on management of Graves' orbitopathy
原文传递
导出
摘要 Graves眼病(GO)的管理存在一些分歧,主要是循证医学的证据太少.为了规范GO的管理,欧洲GO专家组(EUGOGO)组织了相关多学科的专家讨论.最后形成了 EUGOGO共识.该共识的主要内容包括:(1)强调建立多学科组成的甲状腺眼病专科团队,且不主张非专科医生诊治GO.(2)提出了实用的GO病情评估指标.(3)活动性中、重度GO患者可行甲基强的松龙(甲强龙)冲击治疗,且最好与眼眶放射治疗合用.必要时可行减压手术.(4)康复或矫形手术应在GO稳定6个月以上才能进行. There are some disagreements in the management of Graves' orbitopathy (GO) , because of few evidences of evidence-based medicine. In order to standardize the management of GO,GO European Group on GO ( EUGOGO) organized a multi-disciplinary consortium of clinicians for the subsequent discussions and finally formed a consensus statement on management of the disease. The main contents of the consensus are; (1) It is significant to emphasize the establishment of the special team consisting of multi-disciplinary consortium of clinicians for management of GO. It is not advocated that the GO patients would be diagnosed and treated by non-specialists. (2) Some practical evaluations of GO have been suggested. (3) Active moderate-severe GO should be treated with methylprednisolone, and it is better to combine with orbital radiotherapy. Sometimes,orbital decompression should be undertaken. (4) Rehabilitative surgery should only be performed in patients who have had inactive GO for at least 6 months.
作者 张舫 童南伟
出处 《国际内分泌代谢杂志》 2010年第3期145-147,共3页 International Journal of Endocrinology and Metabolism
关键词 GRAVES眼病 管理方案 糖皮质激素 眼窝放射治疗 康复手术 Graves'orbitopathy Management Glucocorticoids Orbital irradiation Rehabilitative surgery
  • 相关文献

参考文献3

二级参考文献6

  • 1黄勤,张家庆.糖胺聚糖在Graves眼病发病学中的作用[J].国外医学(内分泌学分册),1993,13(4):174-177. 被引量:6
  • 2黄勤,国外医学.内分泌学分册,1993年,13卷,4期,174页
  • 3高慧,国外医学.内分泌学分册,1992年,12卷,2期,57页
  • 4廖志强,国外医学.眼科分册,1991年,15卷,5期,284页
  • 5卢启铭,中国实用眼科杂志,1990年,8卷,9期,527页
  • 6廖志强,夏瑞南.Graves眼病的临床[J].中华眼科杂志,1992,28(4):236-239. 被引量:9

共引文献2

同被引文献48

  • 1孙治华,姚斌,翁建平.Graves眼病的诊治新进展[J].国外医学(内科学分册),2005,32(1):21-25. 被引量:22
  • 2刘立民,何彦津.眼眶炎性假瘤的治疗进展[J].国际眼科杂志,2006,6(2):453-455. 被引量:5
  • 3鞠海兵,王光琳,胡灯明,舒子正,朱姿英,沈菲菲.糖皮质激素治疗后TSH受体抗体水平与Graves眼病活动度的相关性[J].中华内分泌代谢杂志,2006,22(5):455-456. 被引量:5
  • 4赵素焱,闵燕.曲安奈德局部注射治疗泪腺炎(附10例临床观察)[J].中国实用眼科杂志,2006,24(11):1199-1201. 被引量:5
  • 5Eckstein AK,Plicht M,Lax H,et al.Clinical results of anti-inflammatory therapy in Graves'ophthalmopathy and association with thyroidal autoantibodies[J].Clin Endocrinol(Oxf),2004,61(5):612-618.
  • 6Lazarus JH.Epidemiology of Graves'orbitopathy(GO)and relationship with thyroid disease[J].Best Pract Res Clin Endocrinol Metab,2012,26(3):273-279.
  • 7Shiber S,Stiebel-Kalish H,Shimon I,et al.Glucocorticoid regimens for prevention of Graves'ophthalmopathy progression following radioiodine treatment:systematic review and meta-analysis[J].Thyroid,2014,24(10):1515-1523.
  • 8Greenhill C.Thyroid gland:Duration of intravenous glucocorticoid therapy in patients with Graves ophthalmopathy[J].Nat Rev Endocrinol,2014,10(1):2.
  • 9Flanders AE, Mafee MF, Rao VM, et al. CT characteristics of orbitial pseudotumors and other orbital inflammatory processes. J Comput Assist Tomogr 1989 ;13 ( 1 ) :40-47.
  • 10Char DH, Mdker T. Orbital pseudotumor. Fine-needle aspiration biopsy and nesponse to therapy. Ophthalmology 1993 ; 100 ( 11 ) : 1702-1710.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部